We are seeing the seeds we planted 25 years ago with the creation of the Foundation come to full bloom. A pillar of our Foundation mission was “to create premier Pancreatic Cancer Center where all needs of pancreatic cancer patients can be met in one location with the most advanced treatment options.” That dream is now the UCLA Agi Hirshberg Center for Pancreatic Diseases and it is moving to a beautiful new space. We’ve had a celebratory sneak peek and look forward to sharing more when the Center opens this summer. This gorgeous new space will offer patients and loved ones world-class integrative care in one convenient location.
As we prepare for the new space, we are honored to welcome Dr. Timothy Donahue as the new Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases. Dr. Donahue is the Garry Shandling Chair of Pancreatic Cancer Surgery, Chief of the Division of Surgical Oncology, and Program Director of the General Surgery Residency at UCLA. He is an expert in the treatment of pancreatic disease and oversees a NIH funded research program focused on pancreatic cancer. With Dr. Donahue as the Director and Dr. Joe Hines as Chair and Executive Medical Director of the Department of Surgery, our pancreatic cancer program at UCLA is in the most capable hands so that all patients can receive best in class care.
Taking the helm of our Scientific Advisory Board will be esteemed researcher, Dr. Miklos Sahin-Toth. Dr. Sahin-Toth has lead his namesake lab at UCLA since 2019. A world-renowned expert in the area of the pancreas disorders with a focus on genetic risk factors in chronic pancreatitis, Dr. Sahin-Toth brings a fresh perspective and talent as Chair of the board, particularly as we look towards the future. For the past 25 years we have invested in progress. Now, we look toward the next 25 years filled with hope for all that is to come.
These exciting changes are possible thanks to those equally invested in our motto, “Never Give Up: Finding a Cure is Worth Fighting For.”
